One longtime Eastern Kentucky dentist is flourishing in an entirely different career during his retirement — moonshining.

This is the prime season for distilleries to release their premium products, just in time for upcoming holiday giving.

Delightfully peaty Scotch whisky, unbelievably flavorful vodka, and the finest rum we’ve ever tasted. These are the best ...

According to Sanders, this new expression from the highly regarded producer reflects two desires of many whiskey drinkers: ...

In the quiet heart of Kentucky's bourbon country, where the air hangs heavy with the scent of charred oak and distant ...

In the heart of South Texas, where the sun beats down like a relentless drum and the air carries the faint whisper of ...

Seagram’s shares the recipe for their Monster Mash Punch with Us Weekly, featuring Seagram’s Escapes Malt Beverages ...

Novo Nordisk has struck a deal to buy Akero Therapeutics for up to $5.2 billion, teeing up a showdown with Roche and others in a blockbuster liver disease market. Akero confirmed its status as a key ...

Acquisition adds potential first- and best-in-class asset, enhancing Novo Nordisk’s portfolio for treatment of MASH, one of the most prevalent obesity related comorbidities Akero Therapeutics’s FGF21 ...

When apples are juiced, their hydrating quality is maximized, and some plant compounds are retained. But juicing reduces other benefits of whole apples, including fiber and the ability to satisfy ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...